Related Experiment Videos
[Estimation of the growth rate of malignant gliomas by CT scanning (author's transl)]
Neurologia Medico-Chirurgica
|November 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Metabolomic responses of an estuarine benthic amphipod to heavy metals at urban-runoff concentrations.
Water science and technology : a journal of the International Association on Water Pollution Research·2019
RETRACTED: Coseismic rupturing stopped by Aso volcano during the 2016 Mw 7.1 Kumamoto earthquake, Japan.
Science (New York, N.Y.)·2016
Preventive effects of kilohertz frequency electrical stimulation on sepsis-induced muscle atrophy.
Journal of musculoskeletal & neuronal interactions·2016
Abnormal asymmetries in subcortical brain volume in schizophrenia.
Molecular psychiatry·2016
Early Volumetric and Biochemical Effects of Embolization in Head and Neck Paragangliomas.
Neurologia medico-chirurgica·2026
Optimal Catheter Size for Medium Vessel Occlusion in Aspiration Thrombectomy.
Neurologia medico-chirurgica·2026
Prospective Evaluation of Standalone Endovascular Embolization for Growing Meningiomas: A Multicenter Study Protocol.
Neurologia medico-chirurgica·2026
Two-point Loop Suture Fixation May Reduce Catheter Displacement in Cisternal and External Ventricular Drains.
Neurologia medico-chirurgica·2026
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026